Midterm Exam MMI 409 Spring 2009 Gordon Bleil

Similar documents
MMI 409 Spring 2009 Final Examination Gordon Bleil. 1. Is there a difference in depression as a function of group and drug?

ANOVA in SPSS (Practical)

Advanced ANOVA Procedures

psy300 / Bizer / Factorial Analyses: 2 x 3 Between-Subjects Factorial Design

SPSS output for 420 midterm study

SPSS output for 420 midterm study

Theoretical Exam. Monday 15 th, Instructor: Dr. Samir Safi. 1. Write your name, student ID and section number.

One-Way Independent ANOVA

PsychTests.com advancing psychology and technology

HS Exam 1 -- March 9, 2006

One-Way ANOVAs t-test two statistically significant Type I error alpha null hypothesis dependant variable Independent variable three levels;

Understandable Statistics

Business Statistics Probability

Overview of Lecture. Survey Methods & Design in Psychology. Correlational statistics vs tests of differences between groups

Analysis of Variance (ANOVA)

Two-Way Independent ANOVA

EPS 625 INTERMEDIATE STATISTICS TWO-WAY ANOVA IN-CLASS EXAMPLE (FLEXIBILITY)

1. Below is the output of a 2 (gender) x 3(music type) completely between subjects factorial ANOVA on stress ratings

Statistics as a Tool. A set of tools for collecting, organizing, presenting and analyzing numerical facts or observations.

1. You want to find out what factors predict achievement in English. Develop a model that

Study Guide for the Final Exam

PSY 216: Elementary Statistics Exam 4

Unit 1 Exploring and Understanding Data

Quantitative Literacy: Thinking Between the Lines

Describe what is meant by a placebo Contrast the double-blind procedure with the single-blind procedure Review the structure for organizing a memo

Chapter 12: Introduction to Analysis of Variance

Analysis of Variance (ANOVA) Program Transcript

Simple Linear Regression the model, estimation and testing

Two-Way Independent Samples ANOVA with SPSS

The t-test: Answers the question: is the difference between the two conditions in my experiment "real" or due to chance?

SPRING GROVE AREA SCHOOL DISTRICT. Course Description. Instructional Strategies, Learning Practices, Activities, and Experiences.

SUMMER 2011 RE-EXAM PSYF11STAT - STATISTIK

Homework Exercises for PSYC 3330: Statistics for the Behavioral Sciences

Problem #1 Neurological signs and symptoms of ciguatera poisoning as the start of treatment and 2.5 hours after treatment with mannitol.

Still important ideas

Describe what is meant by a placebo Contrast the double-blind procedure with the single-blind procedure Review the structure for organizing a memo

Chemistry, Biology and Environmental Science Examples STRONG Lesson Series

Common Statistical Issues in Biomedical Research

Profile Analysis. Intro and Assumptions Psy 524 Andrew Ainsworth

A Brief (very brief) Overview of Biostatistics. Jody Kreiman, PhD Bureau of Glottal Affairs

PSYCHOLOGY 300B (A01) One-sample t test. n = d = ρ 1 ρ 0 δ = d (n 1) d

Still important ideas

Describe what is meant by a placebo Contrast the double-blind procedure with the single-blind procedure Review the structure for organizing a memo

Statistics Assignment 11 - Solutions

Sheila Barron Statistics Outreach Center 2/8/2011

Quantitative Methods in Computing Education Research (A brief overview tips and techniques)

Final Exam PS 217, Spring 2004

Creative Commons Attribution-NonCommercial-Share Alike License

Final Exam PS 217, Fall 2010

LAB ASSIGNMENT 4 INFERENCES FOR NUMERICAL DATA. Comparison of Cancer Survival*

Research paper. One-way Analysis of Variance (ANOVA) Research paper. SPSS output. Learning objectives. Alcohol and driving ability

Readings Assumed knowledge

Simple Linear Regression

PSYCHOLOGY 320L Problem Set #4: Estimating Sample Size, Post Hoc Tests, and Two-Factor ANOVA

Chapter 13: Introduction to Analysis of Variance

Inferential Statistics

PRINCIPLES OF STATISTICS

Readings: Textbook readings: OpenStax - Chapters 1 11 Online readings: Appendix D, E & F Plous Chapters 10, 11, 12 and 14

Dr. Kelly Bradley Final Exam Summer {2 points} Name

Analysis of Variance: repeated measures

STATISTICS & PROBABILITY

Exam 3 PS 217, Spring 2011

Statistics Spring Study Guide

Conditional Distributions and the Bivariate Normal Distribution. James H. Steiger

Comparing Two Means using SPSS (T-Test)

C.3 Repeated Measures ANOVA

Research paper. Split-plot ANOVA. Split-plot design. Split-plot design. SPSS output: between effects. SPSS output: within effects

Use Survey Happiness Complete. SAV file on Blackboard Assigned to Mistake 8

Global Perspective Inventory (GPI) Report

bivariate analysis: The statistical analysis of the relationship between two variables.

11/4/2010. represent the average scores for BOTH A1 & A2 at each level of B. The red lines. are graphing B Main Effects. Red line is the Average A1

Business Research Methods. Introduction to Data Analysis

CLINICAL RESEARCH METHODS VISP356. MODULE LEADER: PROF A TOMLINSON B.Sc./B.Sc.(HONS) OPTOMETRY

Readings: Textbook readings: OpenStax - Chapters 1 13 (emphasis on Chapter 12) Online readings: Appendix D, E & F

Math Section MW 1-2:30pm SR 117. Bekki George 206 PGH

Review and Wrap-up! ESP 178 Applied Research Methods Calvin Thigpen 3/14/17 Adapted from presentation by Prof. Susan Handy

PTHP 7101 Research 1 Chapter Assignments

Skala Stress. Putaran 1 Reliability. Case Processing Summary. N % Excluded a 0.0 Total

!!!!!!!! Aisha Habeeb AL0117. Assignment #2 Part 3. Wayne State University

Learning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency

Analysis of Variance ANOVA, Part 2. What We Will Cover in This Section. Factorial ANOVA, Two-way Design

9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency

Chapter 2 Organizing and Summarizing Data. Chapter 3 Numerically Summarizing Data. Chapter 4 Describing the Relation between Two Variables

BIOL 458 BIOMETRY Lab 7 Multi-Factor ANOVA

Day 11: Measures of Association and ANOVA

Before we get started:

DISCPP (DISC Personality Profile) Psychometric Report

Regression. Page 1. Variables Entered/Removed b Variables. Variables Removed. Enter. Method. Psycho_Dum

Global Perspective Inventory (GPI) - Pilot Report

Repeated Measures ANOVA and Mixed Model ANOVA. Comparing more than two measurements of the same or matched participants

SCHOOL OF MATHEMATICS AND STATISTICS

Exam 2 PS 306, Spring 2004

WDHS Curriculum Map Probability and Statistics. What is Statistics and how does it relate to you?

Applied Statistical Analysis EDUC 6050 Week 4

8/28/2017. If the experiment is successful, then the model will explain more variance than it can t SS M will be greater than SS R

STA 3024 Spring 2013 EXAM 3 Test Form Code A UF ID #

Tutorial 3: MANOVA. Pekka Malo 30E00500 Quantitative Empirical Research Spring 2016

Steps in Inferential Analyses. Inferential Statistics. t-test

Biostatistics. Donna Kritz-Silverstein, Ph.D. Professor Department of Family & Preventive Medicine University of California, San Diego

C2 Training: August 2010

Transcription:

Midterm Exam MMI 409 Spring 2009 Gordon Bleil Table of contents: (Hyperlinked to problem sections) Problem 1 Hypothesis Tests Results Inferences Problem 2 Hypothesis Tests Results Inferences Problem 3 Hypothesis Tests Results Inferences Problem 4 Hypothesis Tests Results Inferences Problem 5 Hypothesis Tests Results Inferences Problem 1 To investigate the effect of a new experimental drug on heart rates, a researcher randomly sampled 12 patients, and randomly assigned 6 patients to an experimental group and 6 patients to a placebo group. The drug therapy and placebo were administered. Two hours after the drug was administered, the number of beats per minute was recorded for each patient. The following results were obtained. Placebo Experimental Drug 63 81 66 76 85 81 69 87 72 72 71 84 Does the new experimental drug significantly affect heart rates? Hypothesis: Research Scenario: From a larger population of patients, a small sample is divided randomly into 2 parts to compare the effects of a new drug against placebo. The question to be answered is whether the new experimental drug significantly affects heart rates. Problem formulation: This question requires the comparison of two test samples. There is no relationship between the measurements on the heart rate of any two patients, and no single patient is measured twice or given both drugs in order to compare effects.

Therefore they are independent samples. Data Definitions/Comments: Heart rate data are obtained two hours after the drug is taken and recorded as beats per minute. Null Hypothesis: H 0 : A B There is no significant difference between the effects of the placebo and the experimental drug based on heart rate. Alternative Hypothesis: H 1 : A = B There is a significant difference between the effects of the placebo and the experimental drug based on heart rate. Statistical Procedure, Tests and Assumptions: Test: T-Test; Independent Samples Level of Significance: α = 0.05 Assumptions: This is a normal population Patients are random selected Samples are independent There is equality of variance Results: Group Statistics Therapy N Mean Std. Deviation Std. Error Mean Heart Rate Placebo 6 71.00 7.616 3.109 Experimental Drug 6 80.17 5.419 2.212 Independent Samples Test t-test for Equality of Means Sig. (2-tailed) Mean Difference Std. Error Difference Heart Rate Equal variances assumed.037-9.167 3.816 Independent Samples Test t-test for Equality of Means 95% Confidence Interval of the Difference Lower Upper Heart Rate Equal variances assumed -17.669 -.664 Inference:

The null hypothesis is rejected, based on ρ=0.037 (<0.05). Therefore it there is a significant difference between the effects of the experimental drug and placebo, and the new experimental drug significantly affects heart rates. The mean heart rate for the experimental drug is higher. The specific goal of the drug was not defined; therefore no inference can be made regarding whether this information is helpful in determining the usefulness or safety of the drug. This is also a small sample, decreasing the likelihood of effective generalization to the larger population. Problem 2 A researcher interested in how trauma impacts different parts of the brain, a random sample of five people were shown graphic images of trauma events. The following data represent levels of EEG activity for the five patients in two different locations of the brain. For each patient, EEG activity was recorded for each section of the brain. Subject EEG Location 1 EEG Location 2 1 3 5 2 4 8 3 2 3 4 4 5 5 7 9 Do the two locations show a difference in the level of EEG activity? Hypothesis: Research Scenario: This is an experiment in which more than one measurement is made on randomly selected individuals with the goal of determining if the measurements vary significantly based on their location. The question to be answered is whether the two locations show a difference in the level of EEG activity. Problem formulation: This a single sample of patients each with two measurements based on the same environmental condition. The data are therefore paired based on their relationship (being measured on the same individual), but neither is completely dependent or independent of each other. Data Definitions/Comments: The measurements are made using the same basic device, located on standardized areas of the head, with the patient in the same basic environment. Measurements are provided in undefined levels between 2 and 9. Null Hypothesis: H 0 : A B There is no significant difference between the measurements at Location 1 and Location 2. Alternative Hypothesis: H 1 : A = B There is a significant difference between the measurements at Location 1 and Location 2. Statistical Procedure, Tests and Assumptions: Test: T-Test; Paired Samples Level of Significance: α = 0.05

Assumptions: This is a normal population Data are random Results: Samples are not independent Paired Samples Statistics There is equality of variance Mean N Std. Deviation Std. Error Mean Pair 1 EEG_Loc_1 4.00 5 1.871.837 EEG_Loc_2 6.00 5 2.449 1.095 Paired Samples Correlations N Correlation Sig. Pair 1 EEG_Loc_1 & EEG_Loc_2 5.873.053 Paired Samples Test Paired Differences Mean Std. Deviation Std. Error Mean Pair 1 EEG_Loc_1 - EEG_Loc_2-2.000 1.225.548 Paired Samples Test Paired Differences 95% Confidence Interval of the Difference Lower Upper Pair 1 EEG_Loc_1 - EEG_Loc_2-3.521 -.479 Paired Samples Test t df Sig. (2-tailed) Pair 1 EEG_Loc_1 - EEG_Loc_2-3.651 4.022

Inference: The null hypothesis is rejected as ρ=0.022 (<0.05). Therefore the two locations show a difference in the level of EEG activity based on the sample data. Of note, there is no significant correlation between the pairs, and although the mean value for Location 1 is less than that of Location 2, neither the clinical accuracy (whether it truly reflects the patient condition) or the clinical significance of this determined based on this information alone. Problem 3 Two groups of children, one with attention deficit disorder (ADD) and a control group of children without ADD, were randomly given either a placebo or the drug Ritalin. A measure of activity was made on all the children with the results shown in the table below (higher numbers indicate more activity). Drug Key: 1=Placebo, 2=Ritalin Group Key: 1=ADD, 2=Control The following data were recorded: Subject Drug Group Activity 1 1 1 90 2 1 1 88 3 1 1 95 4 1 2 60 5 1 2 62 6 1 2 66 7 2 1 72 8 2 1 70 9 2 1 64 10 2 2 86 11 2 2 86 12 2 2 82 How is activity level related to Ritalin and ADD? Hypothesis: Research Scenario: There are two distinct populations of patients, each being given two distinct treatments, looking for the effect of medication as measured by the activity level of the patients. The question to be answered is how activity level is related to Ritalin and ADD. Problem formulation: There are two patient populations and two treatments. There are 4 groups that need to be compared, with the measurement of activity dependent on both diagnosis (Normal and Attention Deficit Disorder [ADD]) and drug (Placebo and Ritalin). Data Definitions/Comments: Null Hypothesis: H 0 : A B There is no significant difference in the activity level of the patients, whether or not they have ADD, and whether or not they receive Ritalin. Alternative Hypothesis: H 1 : A = B There is a significant difference in the activity level of the patients, depending on whether they have ADD, or whether they receive Ritalin.

Statistical Procedure, Tests and Assumptions: Test: Two Way Univariate Analysis of Variance Level of Significance: α = 0.05 Assumptions: This is a normal population Data are random Samples are not independent There is equality of variance Results: Post hoc tests are not performed for Drug because there are fewer than three groups. Post hoc tests are not performed for Group because there are fewer than three groups. Descriptive Statistics Dependent Variable: Activity Drug Group Mean Std. Deviation N Placebo ADD 91.00 3.606 3 Control 62.67 3.055 3 Total 76.83 15.804 6 Ritalin ADD 68.67 4.163 3 Control 84.67 2.309 3 Total 76.67 9.266 6 Total ADD 79.83 12.719 6 Control 73.67 12.291 6 Total 76.75 12.352 12 Tests of Between-Subjects Effects Dependent Variable:Activity Source Type III Sum of Squares df Mean Square F Sig. Corrected Model 1588.250 a 3 529.417 47.059.000 Intercept 70686.750 1 70686.750 6283.267.000 Drug.083 1.083.007.934 Group 114.083 1 114.083 10.141.013 Drug * Group 1474.083 1 1474.083 131.030.000 Error 90.000 8 11.250 Total 72365.000 12 Corrected Total 1678.250 11

Results: Post hoc tests are not performed for Drug because there are fewer than three groups. a. R Squared =.946 (Adjusted R Squared =.926) Estimated Marginal Means Group Dependent Variable:Activity 95% Confidence Interval Group Mean Std. Error Lower Bound Upper Bound ADD 79.833 1.369 76.676 82.991 Control 73.667 1.369 70.509 76.824 Drug * Group Dependent Variable:Activity 95% Confidence Interval Drug Group Mean Std. Error Lower Bound Upper Bound Placebo ADD 91.000 1.936 86.534 95.466 Control 62.667 1.936 58.201 67.132 Ritalin ADD 68.667 1.936 64.201 73.132 Control 84.667 1.936 80.201 89.132

Profile Plots Inference: The corrected model ρ =.000 (<0.05), therefore the null hypothesis is rejected. There is a significant difference between the groups. Both the Group and the Group*Drug levels of significance are <0.05, therefore of significance. However, since the Group affects both of those values, and the Drug ρ>0.05, then only the Group difference is significant. This is consistent with the graph, which shows that the ADD marginal mean crosses the Normal mean when the Drug regimen is considered. Activity level is related to Ritalin and ADD in that patients with ADD show significantly lower levels of activity when given Ritalin in comparison to patients without ADD. Problem 4 Patients of a large community clinic with large call volumes on average experience a 94 second wait time before the call is answered. In an effort to decrease wait time for patients, the clinic hired an additional phone operator. The following wait times were collected on ten randomly selected phone calls on the first day that the additional operator was used. The following wait times in seconds were recorded. 94, 56, 23, 37, 116, 105, 78, 86, 75, 121 Do the data suggest that the additional operator has resulted in lower wait times for patients?

Hypothesis: Research Scenario: The current average length of waiting time is known, and the clinic wants to know if the desired effect of lower average call waiting time was accomplished by the intervention of hiring an additional phone operator. The question is whether the data suggest that the additional operator has resulted in lower wait time for patients. Problem formulation: A sample of caller waiting times is collected to compare against a known standard. There is a single test sample, to be compared to a standard sample mean Data Definitions/Comments: Null Hypothesis: H 0 : A B There is no significant difference between the current average call waiting time of 94 seconds and the new mean call waiting time. Alternative Hypothesis: H 1 : A = B There is a significant difference between the current average call waiting time of 94 seconds and the new mean call waiting time. Statistical Procedure, Tests and Assumptions: Test: T-Test; Single Sample Level of Significance: α = 0.05 Assumptions: This is a normal population Data are random Samples are not independent There is equality of variance Results: One-Sample Statistics N Mean Std. Deviation Std. Error Mean Times 10 79.10 32.539 10.290 One-Sample Test Test Value = 94 95% Confidence Interval of the Difference t df Sig. (2-tailed) Mean Difference Lower Upper Times -1.448 9.182-14.900-38.18 8.38

Statistics Times N Valid 10 Missing 0 Mean 79.10 Median 82.00 Mode 23 a Std. Deviation 32.539 Variance 1058.767 a. Multiple modes exist. The smallest value is shown Inference: The null hypothesis is not rejected as the two tailed ρ=.182 (>0.05). Therefore the data do not suggest that the additional operator has resulted in a lower average phone call waiting time for patients. Although the mean of 79 is apparently different from 94, the wide variation and small sample size calculate to a large Standard Deviation 32, which is easily inclusive of the previous mean.

Problem 5 A researcher is interested in comparing the effect of breastfeeding and baby formula on the growth of newborn babies. 20 babies were randomly selected and randomly assigned to the following groups. After 14 days, the infants were weighed at the same time of day. The following results were recorded in ounces. Group 1: Exclusively breastfed. Group 2: Exclusively with Formula A. Group 3: Exclusively with Formula B. Group 4: Exclusively with Formula C. 112 116 121 98 106 102 103 111 101 104 103 101 112 115 102 95 118 101 97 115 Does the data suggest that that there is a difference among the groups? Hypothesis: Research Scenario: This group of babies is selected from an unknown pool and randomly assigned to a feeding type. Data given are identified as change in weight in ounces. No characteristics of the infants were otherwise described (such as maturity, age [newborn usually includes the first 30 days of life], co-morbid conditions). The question to be answered is whether the data suggest that there is a difference among 4 groups of babies. Problem formulation: There are 4 different formulas being fed to a randomly chosen group of infants. The weights are each related to a baby, but there is no relationship between babies and only one weight gain measure is given for each baby. No baby is fed more than one formula. Data Definitions/Comments: The formulas tested are not described as being the only formulas available, therefore this is not a discrete set of samples. Null Hypothesis: H 0 : A B There is no significant difference between the weights of babies fed different formulas after 14 days. Alternative Hypothesis: H 1 : A = B There is a significant difference between the weights of babies fed different formulas after 14 days. Statistical Procedure, Tests and Assumptions: Test: One-way ANOVA Level of Significance: α = 0.05 Assumptions: This is a normal population Data are random Samples are not independent There is equality of variance

Results: Descriptives Weights N Mean Std. Deviation Std. Error 1 5 115.80 3.899 1.744 2 5 104.40 6.580 2.943 3 5 102.80 5.119 2.289 4 5 103.60 7.266 3.250 Total 20 106.65 7.659 1.713 Model Fixed Effects 5.863 1.311 Random Effects 3.067 Weights Descriptives 95% Confidence Interval for Mean Lower Bound Upper Bound Minimum Maximum Between- Component Variance 1 110.96 120.64 112 121 2 96.23 112.57 98 115 3 96.44 109.16 97 111 4 94.58 112.62 95 115 Total 103.07 110.23 95 121 Model Fixed Effects 103.87 109.43 Random Effects 96.89 116.41 30.762

ANOVA Weights Sum of Squares df Mean Square F Sig. Between Groups 564.550 3 188.183 5.474.009 Within Groups 550.000 16 34.375 Total 1114.550 19 Post Hoc Tests Multiple Comparisons Weights Tukey HSD (I) Group (J) Group Mean Difference 95% Confidence Interval (I-J) Std. Error Sig. Lower Bound Upper Bound 1 2 11.400 * 3.708.033.79 22.01 3 13.000 * 3.708.014 2.39 23.61 4 12.200 * 3.708.022 1.59 22.81 2 1-11.400 * 3.708.033-22.01 -.79 3 1.600 3.708.972-9.01 12.21 4.800 3.708.996-9.81 11.41 3 1-13.000 * 3.708.014-23.61-2.39 2-1.600 3.708.972-12.21 9.01 4 -.800 3.708.996-11.41 9.81 4 1-12.200 * 3.708.022-22.81-1.59 2 -.800 3.708.996-11.41 9.81 3.800 3.708.996-9.81 11.41 *. The mean difference is significant at the 0.05 level.

Homogeneous Subsets Weights Tukey HSD a Subset for alpha = 0.05 Group N 1 2 3 5 102.80 4 5 103.60 2 5 104.40 1 5 115.80 Sig..972 1.000 Means for groups in homogeneous subsets are displayed. a. Uses Harmonic Mean Sample Size = 5.000. Inference: Based on the ρ =.009, (<0.05) the null hypothesis is rejected there is a difference among the groups of baby weight gains based on the formula fed. In Post Hoc analysis, using the multiple comparisons table, it is evident that there is a significant difference between Group 1 and each of the other Groups, but no difference between Groups 2,3 & 4, consistent with the Homogenous Subsets table which shows this same grouping. The mean weight gain for Group 1 is greater than that of the other set of Groups, indicating that Breast Feeding results in significantly greater weight gain than any of the other formulas tests.